CoChat

Naltrexone for alcohol-dependent patients

Ahmadi, J, Babaeebeigi, M, Maany, I, Porter, J, Mohagheghzadeh, M, Ahmadi, N, Dehbozorgi, G · 2004 · Irish Journal of Medical Science

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

Background Clinical trials have shown that naltrexone 50 mg/day reduces alcohol consumption and relapse rates in alcohol dependents. Aim To investigate the efficacy of 50mg/day dose of naltrexone in the maintenance of alcohol-dependent subjects over a 36-week treatment period. Methods Subjects were randomised into two equal groups, consisting of 116 male alcohol-dependent patients who met the DSM-IV criteria for alcohol dependence and were seeking treatment. The participants received naltrexone or placebo at a dose of 50 mg/day and were treated in an outpatient clinic, offering a weekly 0.5-hour individual counselling session. Days retained in treatment were measured. Results Forty-one participants (35.3%) completed the 36-week study. Completion rates by group were 44.8% for the 50 mg naltrexone group and 25.9% for the placebo group (chi2=4.56, DF=1, 2-sided significance=0.033). Conclusion The results support the efficacy and safety of naltrexone for outpatient treatment of alcohol-dependent individuals in Iran.

Overview

Integrity signals

Registry

Crossref · 10.1007/bf02914522

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

19 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Research works printed but not linked: 6

  1. World Health Organisation. The ICD-10 Classification of Mental and Behavioral Disorders-diagnostic criteria for research (Geneva, World Health Organisation) 1996.
  2. Anthony JC, Wa rner LA, Kessler RC. Comparative epidemiology of dependence on tobacco, alcohol, controlled substance and inhalants: basic findings from the National Comacology survey.Clin Expl Pharmacol 1994; 2: 244–68.
  3. Volpicelli JR, Watson NT, King AC, Sherman CE, O’Brien CP. Effect of naltrexone on alcohol “high” in alcoholics.Am J Psychiat 1997; 152: 613- 5.
  4. Litten RZ, Ferti GJ. International update: new findings on promising medications. Alcoholism:Clin Exp Res 1996; 20: 216A-18A. · DOI
  5. Volpicelli JR, Davis MA, Olgin JE. Naltrexone blocks the post-shock increase in ethanol consumption.Life Sci 1986; 38: 41–7. · DOI · Paper page
  6. Hubbell CL, Marglin SH, Sitalnic SJ, Abelson ML, Wild KD, Reid LD. Opioidergic, serotonergic, and dopaminergic manipulations and rats’ intake of a sweetened alcoholic beverage.Alcohol 1991; 8: 355–67. · DOI

Cited by

See all 23

Metadata

Authors
Ahmadi, J., Babaeebeigi, M., Maany, I., Porter, J., Mohagheghzadeh, M., Ahmadi, N., & Dehbozorgi, G.
Affiliations
Shiraz University of Medical Sciences (IR)
Corresponding author
Ahmadi, J
Venue
Irish Journal of Medical Science
Published
2004-01
Volume
173
Issue
1
Pages
34-37
ISSN
  • 0021-1265 (ISSN-L)
  • 1863-4362
OpenAlex
W2083502263
Cited by
22
References
25
Citations by year
2023: 1 · 2022: 3 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 3 · 2017: 1 · 2016: 4 · 2013: 1 · 2012: 1
FWCI
0.24
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Irish Journal of Medical Science (1971 -) (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
  • Health Sciences › Medicine › Clinical Neurology › Alcoholism and Thiamine Deficiency
Keywords
naltrexone, alcoholism, outpatient care, treatment retention, relapse prevention, pharmacotherapy, individual counseling
MeSH terms
Adult, Alcoholism, Double-Blind Method, Humans, Iran, Male, Middle Aged, Naltrexone, Narcotic Antagonists, Recurrence, Chi-Square Distribution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.